Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel AR antagonist ZR-291 exhibits potent preclinical activity in prostate cancer

Dec. 4, 2009

Small-molecule compound BRA-101 reduces DSS-induced murine colitis

Dec. 4, 2009

FIELD trial data support beneficial effects of fenofibrate in type 2 diabetes patients

Dec. 4, 2009

Prasugrel more effective than clopidogrel in CAD patients with type 2 diabetes

Dec. 4, 2009

New camptothecin conjugate evaluated in phase I trial in advanced solid tumors

Dec. 4, 2009

GSK-2126458 shows potent preclinical antitumor activity; phase I trial under way

Dec. 4, 2009

Data from phase I study on AS-703569 disclosed at 2009 AACR-NCI-EORTC meeting

Dec. 3, 2009

Interim data presented from AV-412 phase I trial in advanced solid tumors

Dec. 3, 2009

TRIN-2755 exhibits antitumor activity in multiple xenograft mouse models

Dec. 3, 2009

MK-1775 exhibits synergism with gemcitabine in pancreatic tumors in vivo

Dec. 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026